Priority dates, work visas, and labor market data
H-1B & Green Card Sponsorship Data
Source: US Dept of Labor. Represents Base Salary only. Excludes RSUs, signing bonuses, and variable compensation. View All Salary RecordsTotal Filings
2021-PresentApproval Rate
Certified CasesMedian Salary
Across All RolesYoY Growth
Filing Volume| Program | Last Filing | Total (2021–Present) |
|---|---|---|
| H-1B | Feb 5, 2024 | 4 |
| PERM | Mar 16, 2022 | 2 |
| Role | Last Filing | Total (2021–Present) |
|---|---|---|
| Manager, Global Commercial Strategy | Feb 5, 2024 | 1 |
| Sr. Director, Transactions Immunology, Acquisitions | Jan 5, 2024 | 2 |
| Director, Global Strategic Marketing , Multiple Myeloma | Apr 7, 2022 | 1 |
| Director, Patient Reported Outcomes | Mar 16, 2022 | 1 |
| Senior Global Medical Affairs Leader, Myeloid Malignancies | Sep 16, 2021 | 1 |
| Role | Count | Median Salary | Min | Max |
|---|---|---|---|---|
| Sr. Director, Transactions Immunology, Acquisitions | 2 | $299,100 | $295,000 | $303,200 |
| Director, Global Strategic Marketing , Multiple Myeloma | 1 | $234,200 | $234,200 | $234,200 |
| Director, Patient Reported Outcomes | 1 | $187,900 | $187,900 | $187,900 |
| Head of Market Access, Oncology | 1 | $372,000 | $372,000 | $372,000 |
| Manager, Global Commercial Strategy | 1 | $248,900 | $248,900 | $248,900 |
| Senior Global Medical Affairs Leader, Myeloid Malignancies | 1 | $332,002 | $332,002 | $332,002 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| FY 2022 | 3 | $287,067 | 100.0% |
| FY 2023 | 1 | $187,900 | 100.0% |
| FY 2024 | 2 | $276,050 | 100.0% |
| FY 2025 | 1 | $372,000 | 100.0% |